SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
📖

Amyotrophic Lateral Sclerosis (ALS) Genetic Variants

active
wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-als-genetic-variants
Related Entities
diseases-als-genetic-variants
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
45
Outgoing
89
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (134)
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
mentions🧫TDP-43 mitochondrial invasion and DNA release via mPTP60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples60%
mentions🧪Glycine-Rich Domain Competitive Inhibition60%
mentions🔬How do non-cell autonomous effects of autophagy dysfunction 60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
mentions🧫cGAS/STING pathway activation by TDP-43-released mtDNA60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples60%
mentions🧪Cryptic Exon Silencing Restoration60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
mentions🔬RNA binding protein dysregulation across ALS FTD AD60%
related🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto60%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD60%
mentions🧫TDP-43 mutant mouse model cGAS/STING pathway analysis60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
mentions🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto60%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%
related🧫TDP-43 mutant mouse model cGAS/STING pathway analysis60%
mentions🧪Cross-Seeding Prevention Strategy60%
mentions🧫cGAS/STING pathway validation in TDP-43 mutant mice60%
related🧫TDP-43 mitochondrial invasion and DNA release via mPTP60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples60%
related🧫cGAS/STING pathway activation by TDP-43-released mtDNA60%
related🧫cGAS/STING pathway validation in TDP-43 mutant mice60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples60%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic55%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring55%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development55%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP55%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio55%
mentions🧫Brainstem Circuit Modulation for PSP55%
mentions🧫PSP and CBS Biomarker Validation Study55%
mentions🧫Sleep and Respiratory Network Interaction in ALS — Experimen55%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk55%
mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD55%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers55%
mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des55%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker55%
mentions🧫Metabolic Pathway-Targeted Therapy in ALS55%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS55%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri55%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT55%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design55%
mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study55%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧪Glycine-Rich Domain Competitive Inhibition54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫cGAS/STING pathway activation by TDP-43-released mtDNA54%
related🧫cGAS/STING pathway validation in TDP-43 mutant mice54%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples54%
related🔬RNA binding protein dysregulation across ALS FTD AD54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧪Cross-Seeding Prevention Strategy54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🔬Analyze the spectrum of microglial activation states (DAM, h54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🔬What are the mechanisms underlying tdp-43 phase separation t54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧪Cryptic Exon Silencing Restoration54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🔬What are the mechanisms underlying rna binding protein dysre54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto54%
related🔬RNA binding protein dysregulation across ALS FTD and AD54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
related🧫TDP-43 mitochondrial invasion and DNA release via mPTP54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🔬How do non-cell autonomous effects of autophagy dysfunction 54%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫TDP-43 mutant mouse model cGAS/STING pathway analysis54%
related🧫Brainstem Circuit Modulation for PSP54%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🧪Axonal RNA Transport Reconstitution50%
related🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr50%
mentions🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter50%
related🧪RNA Granule Nucleation Site Modulation50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🧪Multi-Modal Stress Response Harmonization50%
related🧪Stress Granule Phase Separation Modulators50%
related🧪Phase-Separated Organelle Targeting50%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen50%
mentions🧫Endothelium-specific TBK1 knockdown in atherosclerosis model50%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model50%
mentions🧫TBK1-PAK1IP1-PAK1 signaling pathway analysis50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
mentions🧫Experiment: Multi-Ethnic PD GWAS44%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub